Clearstead Advisors’s Hinge Health HNGE Stock Holding History

Clearstead Advisors’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.04K	Buy	+21	New	+$1.84K	﹤0.01%	2466

Other funds holding HNGE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Clearstead Advisors's HNGE Position: Q3 2026 in Review

Clearstead Advisors opened a new position in Hinge Health (HNGE) in Q3 2026: 21 shares worth $2.04K. The stake represents ﹤0.01% of the portfolio and ranks #2466 among its holdings.

138 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

Clearstead Advisors held 21 shares of Hinge Health worth $2.04K as of Q3 2026.
Hinge Health was a new Clearstead Advisors position in Q3 2026.
Hinge Health made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #2466 holding.
138 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.